India Wearables in Pharma & Biotech Market Size, Share,Trends, Growth Analysis Report, 2031

Name: India Wearables in Pharma & Biotech Market Size, Share,Trends, Growth Analysis Report, 2031
Creator: MarketsandMarkets

Overview Request Sample Pages Request Customization Download PDF

You are viewing: India Wearables in Pharma & Biotech Market analysis

Part of: Wearables in Pharma & Biotech Market (Global)

The India Wearables in Pharma & Biotech Market was valued at $153.6 Million in 2026 and projected to reach to $429.3 Million by 2031, representing a compound annual growth rate of 22.8%. India's wearables in pharma and biotech market is poised for exceptional growth, expanding from USD 153.6 million in 2026 to USD 429.3 million by 2031.

India Wearables in Pharma & Biotech Market (2026-2031) : Size and Share

CAGR of

USD Million

India Wearables in Pharma & Biotech Market Trends and Insights

This represents a compound annual growth rate (CAGR) of 22.8%, significantly outpacing global trends.
India's digital health infrastructure, rising smartphone penetration, and increasing adoption of remote patient monitoring solutions are driving demand for wearable medical devices across the country. The Indian market is benefiting from government initiatives promoting digital health, growing healthcare awareness, and a large patient population seeking affordable monitoring solutions.
India's pharmaceutical and biotech sectors are increasingly integrating wearable technology into clinical trials and patient management programs.
By 2031, India is expected to emerge as a key regional hub for wearable pharma applications, supported by a skilled workforce and expanding healthcare IT ecosystem. India's competitive advantage lies in its cost-effective manufacturing capabilities and innovation in mobile health solutions.
The market encompasses continuous glucose monitors, cardiac patches, smart inhalers, and remote monitoring devices tailored to India's healthcare needs.
Strategic partnerships between Indian biotech firms and global wearable manufacturers are accelerating market penetration across urban and semi-urban regions..

Key Market Statistics

CAGR (2026-2031) 22.8% CAGR
Market Size, 2026 ~USD 153.6 Million
Forecast, 2031 ~USD 429.3 Million
Country India

India Wearables in Pharma & Biotech Market Overview

Fastest Growing Market in Asia :

India's wearables in pharma and biotech market is growing at 22.8% CAGR, outpacing the global growth rate of 20.2%, positioning it as a key growth engine in the Asia-Pacific region.

Digital Health Infrastructure Expansion :

India's rapidly evolving digital health ecosystem, supported by government initiatives like Ayushman Bharat and National Digital Health Mission, is driving adoption of wearable monitoring devices across healthcare providers.

Rising Smartphone Penetration :

With over 750 million smartphone users in India, the penetration rate enables seamless integration of wearable devices with mobile health applications, facilitating remote patient monitoring at scale.

Remote Patient Monitoring Adoption :

Increasing demand for telehealth and remote monitoring solutions post-pandemic has accelerated wearable adoption among Indian healthcare facilities, particularly in chronic disease management and preventive care.

India Wearables in Pharma & Biotech Market Dynamics

This trajectory reflects India's transformation into a digital-first healthcare economy, driven by government support, rising healthcare expenditure, and growing awareness of preventive medicine among consumers.
The market benefits from a large patient population, increasing prevalence of chronic diseases, and a cost-conscious healthcare system seeking efficient monitoring solutions. Key growth catalysts include expanding rural healthcare connectivity, rising middle-class disposable income, and pharmaceutical companies' investments in wearable-integrated drug delivery systems.
India's position as a global biotech hub and manufacturing center further strengthens the market, with local players developing affordable wearable solutions tailored to Indian healthcare needs.
Strategic partnerships between tech companies and healthcare providers are expected to accelerate market penetration across urban and semi-urban regions..

Related Ecosystem

Healthcare It

Top Technologies

Computed Tomography (CT)
Machine Learning
Magnetic Resonance Imaging (MRI)
Natural Language Processing (NLP)
Predictive Analytics

Top Companies

CERNER CORPORATION
PHILIPS HEALTHCARE
Oracle Corporation
GE HealthCare Technologies Inc.
Siemens healthineers

Key Takeaways

India's wearables in pharma & biotech market is projected to grow from USD 153.6M (2026) to USD 429.3M (2031) at a 22.8% CAGR.
India's digital health infrastructure and government initiatives are primary catalysts for wearable adoption in pharmaceutical and biotech applications.
India's cost-effective manufacturing and innovation in mobile health position the country as a regional leader in wearable pharma technology.
Remote patient monitoring and chronic disease management are key growth drivers in India's wearables market through 2031.

Wearables in Pharma & Biotech Market Report Scope

Report Metric	Details
Base Year	2026
Fastest Growing Segment	MENTAL HEALTH & BEHAVIORAL HEALTH (Therapeutic Area)
Forecast Period	2026�2031
Growth Rate	CAGR of 20.2% from 2026 to 2031
Largest Segment	PHARMACEUTICAL & BIOTECH COMPANIES (End User)
Market Size Base Year (Billions)	~USD 3.97 (2026)
Revenue Forecast (Billions)	~USD 9.97 (2031)
Segments Covered	Product, Therapeutic Area, Type, Application, End User

India Wearables in Pharma & Biotech Market Report Segmentation

5 segment dimensions are covered across the global market.

By Product

Continuous Glucose Monitors
Fitness Bands
Other Products
Patches
Smart Rings
Smartwatches
Wearable Injectors

By Therapeutic Area

Cardiovascular
Diabetes
Lifestyle & Wellness Improvement
Mental Health & Behavioral Health
Musculoskeletal Disorders/Pain Management
Neurology
Oncology
Other Diseases
Respiratory Disorders
Women�S Health & Reproductive Health

By Type

Atherosclerotic Cardiovascular Diseases/Secondary Prevention
Atrial Fibrillation/Stroke Prevention
Brain Tumor
Breast Cancer
Colorectal Cancer
Heart Failure
Hematologic Malignancies
Hypertension
Leukemia
Lung Cancer
Lymphoma
Multiple Myeloma
Other Hematologic Malignancies
Other Solid Tumors
Phase Ii
Phase Iii
Phase Iv
Prostate Cancer
Pulmonary Hypertension
Solid Tumors
Structural Heart Diseases/Interventional Cardiology

By Application

Chronic Disease Monitoring
Clinical Trials
Drug Discovery
Medication Adherence & Behavioral Support
Personalized & Preventive Digital Therapeutics

By End User

Contract Research Organizations
Healthcare Providers & Clinicians
Other End Users
Pharmaceutical & Biotech Companies

INDIA: WEARABLES IN PHARMA & BIOTECH MARKET, BY END USER, 2024�2031

Segment	2024	2025	2026	2027	2028	2029	2030	2031	CAGR (%)
CONTRACT RESEARCH ORGANIZATIONS	34.5	42	51.5	63.4	78.3	97	120.7	150.5	23.9
HEALTHCARE PROVIDERS & CLINICIANS	10.3	12.3	14.8	17.9	21.8	26.5	32.4	39.6	21.7
OTHER END USERS	7.8	9.2	11	13.3	16	19.3	23.3	28.2	20.6
PHARMACEUTICAL & BIOTECH COMPANIES	52.2	62.9	76.2	92.8	113.4	139	171	210.9	22.6
TOTAL	104.8	126.5	153.6	187.3	229.4	281.8	347.4	429.3	22.8

Target Audience

Pharmaceutical Companies : Pharma firms need India market data to develop wearable-integrated drug delivery systems, conduct real-world evidence studies, and expand patient monitoring capabilities in India's growing therapeutic markets.
Biotech Startups and Innovators : Indian and international biotech startups require market sizing and growth forecasts to secure funding, validate business models, and identify partnership opportunities with healthcare providers and pharmaceutical partners.
Medical Device Manufacturers : Device makers need India-specific insights to understand market demand, regulatory requirements, manufacturing opportunities, and distribution strategies for wearable health monitoring devices.
Healthcare Providers and Hospital Networks : Indian hospitals and healthcare systems need market intelligence to evaluate wearable technology investments, understand patient adoption trends, and plan digital health infrastructure expansion.
Investors and Private Equity Firms : Investment professionals require detailed India market analysis to identify high-growth opportunities, assess portfolio company potential, and make informed decisions on healthcare technology investments in the region.

Key Companies in the India Wearables in Pharma & Biotech Market

Company	HQ	Ownership	Strongest segments

Reasons to Buy this Report

Market Entry Strategy for India : Gain comprehensive insights into India's high-growth wearables market to develop localized go-to-market strategies, identify key distribution channels, and understand regulatory pathways specific to Indian pharma and biotech sectors.
Competitive Landscape Analysis : Understand India-specific competitive dynamics, identify emerging local players and multinational competitors, and benchmark your offerings against market leaders operating in the Indian wearables ecosystem.
Investment and Funding Opportunities : Identify high-potential segments and regions within India's wearables market to guide investment decisions, venture capital allocation, and partnership opportunities with Indian healthcare and biotech enterprises.
Regulatory and Compliance Insights : Navigate India's complex regulatory environment including CDSCO approvals, medical device classifications, and data privacy requirements specific to wearable health devices and remote monitoring solutions.
Consumer and Provider Adoption Trends : Understand India-specific adoption patterns among healthcare providers, patients, and pharmaceutical companies, including barriers to adoption, price sensitivity, and preferences for wearable features and integrations.

Frequently asked questions

What is the current market size of wearables in pharma & biotech in India?

India's wearables in pharma & biotech market was valued at USD 153.6 million in 2026 and is expected to grow to USD 429.3 million by 2031.

What is the projected CAGR for India's wearables in pharma & biotech market?

India's wearables in pharma & biotech market is projected to grow at a compound annual growth rate (CAGR) of 22.8% from 2026 to 2031.

What are the main drivers of growth in India's wearables pharma market?

Key growth drivers in India include digital health infrastructure expansion, government digital health initiatives, rising smartphone penetration, increasing remote patient monitoring adoption, and a large patient population seeking affordable healthcare solutions.

Which wearable devices are most prevalent in India's pharma & biotech market?

India's market includes continuous glucose monitors, cardiac patches, smart inhalers, remote monitoring devices, and wearables designed for chronic disease management tailored to local healthcare needs.

How does India's wearables market compare to global trends?

India's 22.8% CAGR significantly exceeds the global CAGR of 20.2%, positioning India as a high-growth market within the Asia Pacific region for wearables in pharma & biotech.

RESEARCH METHODOLOGY

This study involved five major activities to estimate the current size of the wearables in pharma & biotech market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of the wearables in pharma & biotech market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global wearables in pharma & biotech market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Wearables in Pharma & Biotech Market
Size, and Share

Note: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million. Other designations include sales managers, marketing managers, and product managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the wearables in pharma & biotech market. These methods were also used extensively to estimate the size of various subsegments in the market.

The research methodology used to estimate the market size includes the following:

Wearables in Pharma & Biotech Market : Top-Down and Bottom-Up Approach

Data Triangulation

After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the wearables in pharma & biotech market.

Market Definition

The wearables in pharma & biotech market comprise sensor-based, body-worn, or minimally invasive devices and associated digital platforms used to capture continuous physiological and behavioral data across the drug development and healthcare continuum. This includes products such as smartwatches, fitness bands, smart rings, continuous glucose monitors (CGMs), wearable patches, and wearable injectors, which enable real-time monitoring of parameters like heart rate, glucose levels, activity, and treatment adherence. These technologies are applied across a wide range of therapeutic areas, including cardiovascular diseases, oncology (solid tumors and hematologic malignancies), diabetes, mental health, respiratory, neurological, musculoskeletal, and women’s health conditions. The market spans key applications, such as drug discovery, clinical trials (Phase II–IV), medication adherence, chronic disease monitoring, and personalized digital therapeutics, supporting decentralized trials and real-world evidence generation. End users primarily include pharmaceutical and biotechnology companies, healthcare providers, and research organizations, all leveraging wearable technologies to enable data-driven, patient-centric care and more efficient drug development.

Key Stakeholders

Wearable device & biosensor manufacturers (smartwatches, CGMs, patches, smart rings, wearable injectors)
Digital health & software platform providers (mobile apps, cloud platforms, AI analytics)
Component, sensor, & semiconductor technology providers
Pharmaceutical companies
Biotechnology companies
Contract research organizations (CROs)
Clinical trial sponsors & site management organizations
Healthcare providers (hospitals, clinics, remote patient monitoring programs)
Patients & caregivers
Payers & insurers
Regulatory & public health authorities (e.g., US Food and Drug Administration, European Medicines Agency)
Academic institutions & research organizations
Data management, interoperability & cloud infrastructure providers
Cybersecurity & data privacy solution providers
System integrators & IT service providers
Venture capital & private equity firms
Investors & financial institutions
Consulting, regulatory, & compliance service providers

Report Objectives

To define, describe, and forecast the wearables in pharma & biotech market based on product, therapeutic area, application, end user, and region
To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing market growth
To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To strategically analyze the market structure profile of the key players and comprehensively analyze their core competencies
To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, product approvals, and alliances in the market

Customization Options:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of each company.

Geographic Analysis

Further breakdown of the Latin America, Europe, and the Middle East & Africa markets into specific countries

Get the Full Wearables in Pharma & Biotech Market Report

Full forecast, segment splits, and company analysis for all Wearables in Pharma & Biotech Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)